Parallax Volatility Advisers, L.P. Esperion Therapeutics, Inc. Transaction History

Parallax Volatility Advisers, L.P.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.96 - $1.79 $5,497 - $10,251	-5,727 Reduced 34.31%	10,967 $10,000
Q2 2023 Aug 14, 2023	BUY	$1.2 - $1.76 $20,032 - $29,381	16,694 New	16,694 $23,000
Q4 2021 Feb 14, 2022	BUY	$4.81 - $11.92 $135,536 - $335,881	28,178 New	28,178 $141,000
Q3 2020 Nov 13, 2020	SELL	$31.18 - $52.71 $555,004 - $938,238	-17,800 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$30.04 - $51.31 $119,048 - $203,341	-3,963 Reduced 18.21%	17,800 $913,000
Q2 2019 Aug 14, 2019	BUY	$40.1 - $52.33 $872,696 - $1.14 Million	21,763 New	21,763 $1.01 Million
Q1 2019 May 15, 2019	SELL	$40.11 - $53.57 $1.11 Million - $1.48 Million	-27,653 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$36.99 - $59.11 $628,756 - $1 Million	16,998 Added 159.53%	27,653 $1.27 Million
Q2 2018 Aug 14, 2018	BUY	$36.2 - $76.4 $385,711 - $814,042	10,655 New	10,655 $418,000
Q1 2018 May 15, 2018	SELL	$65.94 - $80.76 $168,938 - $206,907	-2,562 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$43.47 - $67.43 $343,717 - $533,169	-7,907 Reduced 75.53%	2,562 $169,000
Q3 2017 Nov 14, 2017	BUY	$43.8 - $52.77 $458,542 - $552,449	10,469	10,469 $525,000

206

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $153M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.